In this article we focused on the challenges encountered during the process of http://www.selleckchem.com/products/Oligomycin-A.html implementing the study design. We would, however, be MEK162 ARRY-162 remiss not to acknowledge the potential burden participation in this study may have had on family members during their time of grief.
Nevertheless it is also important to report that the vast majority of people who contacted us about participation were very positive about our objective to examine the experience of EOLC in our province from their perspective. Most explicitly expressed their appreciation Inhibitors,research,lifescience,medical for having the opportunity to talk about their loved one’s care and to potentially help in shaping future EOLC improvements. In addition, providers of EOLC were also keenly interested and supportive of this study’s results which provide a population-based perception of the experience of EOLC tapping many issues where little or no population estimates have been available . In summary, although Inhibitors,research,lifescience,medical administration of a population-based mortality follow-back survey assessing the experiences of care during the end of life from the bereaved family members’ perspective has become increasingly challenging, due in large part to ethical and privacy concerns, this form of research
can be successfully implemented Inhibitors,research,lifescience,medical and result in a wealth of information previously unavailable at a population level. Inhibitors,research,lifescience,medical Information gathered from the bereaved will provide a better understanding of the experience of EOLC which in turn can be used to promote positive change and better services for the dying and their families. Abbreviations EOLC: End of life care. Competing interests The authors declare that they have no competing interests. Authors’ contributions BL participated in the conceptualization and design
of the study, acted as coordinator, aided in the statistical analyses, drafted and finalized the manuscript. KV aided in the coordination of data collection, performed statistical analyses and helped to draft and finalize the manuscript. FB conceived the study, Inhibitors,research,lifescience,medical participated in the design and coordination and helped to finalize the manuscript. All authors read and approved the Drug_discovery final manuscript. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1472-684X/12/28/prepub Acknowledgements We wish to thank the management and staff of Nova Scotia Vital Statistics for their invaluable help with this project and all the people of Nova Scotia contacted by us to participate. We would also like to acknowledge our two survey interviewers, Jillian Demmons and Cassandra Yonder for their devotion to the bereaved and their compassionate listening skills. Funding Funding for this study was provided by an operating grant awarded from the Canadian Institute for Health Research, MOP-93711.